BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7884153)

  • 1. Vagal efferent nerve-dependent inhibitory action of pancreatic polypeptide and peptide YY in conscious rats: comparison with somatostatin.
    Masuda M; Tomita H; Okubo K; Miyasaka K
    J Auton Nerv Syst; 1994 Dec; 50(2):131-8. PubMed ID: 7884153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory regulation of rat exocrine pancreas by peptide YY and pancreatic polypeptide.
    Putnam WS; Liddle RA; Williams JA
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G698-703. PubMed ID: 2565088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of somatostatin on cholecystokinin release is independent of luminal cholecystokinin-releasing factor content in conscious rats.
    Miyasaka K; Masuda M; Kanai S; Ohta M; Suzuki S; Tateishi K; Funakoshi A
    Pancreas; 2001 Nov; 23(4):414-20. PubMed ID: 11668212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central somatostatin prevents vagal efferent nerve excitation produced by TRH but not by 2-deoxy-D-glucose.
    Masuda M; Kanai S; Miyasaka K
    Am J Physiol; 1997 Feb; 272(2 Pt 1):G351-6. PubMed ID: 9124360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin inhibits pancreatic exocrine secretion centrally via sympathetic nerves in conscious rats.
    Masuda M; Kanai S; Miyasaka K; Funakoshi A
    J Auton Nerv Syst; 1995 Dec; 56(1-2):31-7. PubMed ID: 8786277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic polypeptide and peptide YY inhibit the denervated canine pancreas.
    DeMar AR; Taylor IL; Fink AS
    Pancreas; 1991 Jul; 6(4):419-26. PubMed ID: 1876598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic polypeptide and peptide YY3-36 induce Ca2+ signaling in nodose ganglion neurons.
    Iwasaki Y; Kakei M; Nakabayashi H; Ayush EA; Hirano-Kodaira M; Maejima Y; Yada T
    Neuropeptides; 2013 Feb; 47(1):19-23. PubMed ID: 22944736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pancreatic polypeptide and peptide YY on pancreatic blood flow and pancreatic exocrine secretion in the anesthetized dog.
    DeMar AR; Lake R; Fink AS
    Pancreas; 1991 Jan; 6(1):9-14. PubMed ID: 1994383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
    Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC
    Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: cholinergic mechanisms.
    Wager-Pagé SA; Raizada E; Veale W; Davison JS
    Can J Physiol Pharmacol; 1993; 71(10-11):768-75. PubMed ID: 8143235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of unstimulated exocrine pancreatic secretion by peptide YY in the rat.
    Robinson DC; Rudnicki M; Tito JM; Gold MS
    World J Surg; 1996 Feb; 20(2):208-14. PubMed ID: 8661819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of synthetic human gastrin-releasing peptide on pancreatic exocrine secretion and release of pancreatic polypeptide in conscious rats.
    Miyasaka K; Miyazaki K; Funakoshi A; Kitani K; Yajima H
    Int J Pancreatol; 1989 Apr; 4(3):251-60. PubMed ID: 2760512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central inhibitory action of peptide YY on gastric motility in rats.
    Chen CH; Rogers RC
    Am J Physiol; 1995 Oct; 269(4 Pt 2):R787-92. PubMed ID: 7485594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The area postrema lesions alter the inhibitory effects of peripherally infused pancreatic polypeptide on pancreatic secretion.
    Deng X; Wood PG; Sved AF; Whitcomb DC
    Brain Res; 2001 May; 902(1):18-29. PubMed ID: 11376591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central administration of ghrelin stimulates pancreatic exocrine secretion via the vagus in conscious rats.
    Sato N; Kanai S; Takano S; Kurosawa M; Funakoshi A; Miyasaka K
    Jpn J Physiol; 2003 Dec; 53(6):443-9. PubMed ID: 15040854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vagal cooling blocks circulating neuropeptide Y (NPY), peptide YY (PYY), and pancreatic polypeptide (PP) release.
    Rudnicki M; Rigel DF; McFadden DW
    J Surg Res; 1991 Jul; 51(1):40-5. PubMed ID: 2067357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of pancreatic secretion by vagal nerve during short-term duct occlusion in conscious rats.
    Suzuki S; Kanai S; Miyasaka K; Jimi A; Funakoshi A
    Pancreas; 2000 Jan; 20(1):94-101. PubMed ID: 10630389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats.
    Li Y; Owyang C
    Gastroenterology; 1994 Aug; 107(2):525-31. PubMed ID: 8039628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of somatostatin and pancreastatin on secretion of gastrin, pancreatic polypeptide, and peptide YY.
    Gomez G; Udupi V; Greeley GH
    Proc Soc Exp Biol Med; 1997 Jun; 215(2):165-7. PubMed ID: 9160043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.